A new HIMSS Analytics study of 129 C-suite executives, IT professionals, clinicians and department heads has found 79.8 percent use tablets and 42.6 percent use smartphones to access the information needed to provide and coordinate care. On the other hand, 37.2 percent use laptops and 94.6 ...
See clinical data, get information on patient support options, savings, and learn more about this FDA-approved beta-3 adrenergic agonist for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
For Healthcare Professionals October isBreast Cancer Awareness Month, and we’re here to support you. See TRUQAP resources TRUQAP+fulvestrant can give you more progression-free tomorrows* Explore Results TRUQAP+fulvestrant gives people~2.5x longerwithout their cancer growing or spreading vs hormone ...
Azithromycin Tablets package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Gabapentin Tablets package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Escitalopram Tablets package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
•Talk to your healthcare provider if you do not think that your condition is getting better with TRINTELLIX treatment.Do not take TRINTELLIX if you:•are allergic to vortioxetine, or any of the ingredients in TRINTELLIX. See the end of this Medication Guide for a complete list of ...
Ritonavir Tablets package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
FOR US HEALTH CARE PROFESSIONALS ONLY MEDICAL RESOURCES PRESCRIBING INFORMATION PATIENT WEBSITE REQUEST SAMPLES CHOOSE INDICATION CLL/SLL R/R MCL isi content No PPI restrictions with tablet formulation1 LEADING A NEW ERA IN BTK INHIBITION A highly selective* next-generation BTKi2 Relapsed...
Patients prescribed cladribine tablets (taken for =10 days per year for 2 years), indicated for adults with highly active relapsing MS in the EU and Australia, can benefit from an active partnership with their healthcare professionals, including MS nurses, who can promote a...